Isomyosamine not checked
TNF Pharmaceuticals, Inc. · MYMD-1 · MYMD1 600mg
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Sarcopenia in Elderly, Frailty, Frailty/Sarcopenia, Frailty in Older Adults
- Main trialPhase 2
- “This Phase II clinical study investigates the safety and effectiveness of a new drug, Isomyosamine, in patients with sarcopenia or frailty, conditions associated with aging and muscle weakness. Isomyosamine is a promising oral medication that reduces inflammation by targeting cytokines like TNF-α and IL-6, which are linked to these conditions. Previous studies have shown it is well-tolerated and may help improve muscle strength, mobility, and healing after hip fractures. This trial aims to determine its potential benefits in reducing inflammation and improving recovery in elderly patients.”In the company’s words, NCT06942182 on ClinicalTrials.gov
- Other names
- MYMD-1 · MYMD1 600mg · MYMD1 750mg · MYMD1 900mg · MYMD1 1050mg
Other drugs for Sarcopenia in Elderly
- PLH-2301Pluto Inc. · Phase 2
- TJ0113Hangzhou PhecdaMed Co., Ltd. · Phase 2
- MF-300Epirium Bio Inc. · Phase 2
- Bone marrow mesenchymal stem cellsGuangZhou Cellgenes Biotechnology Co., Ltd. · Phase 1/2
- BimagrumabEli Lilly · Phase 2
- EN001ENCell · Phase 1/2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 1 Mar 2026 | Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures | |
| Phase 2Completed | 7 Jun 2023 | Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty | |
| Phase 1Completed | 1 Aug 2021 | Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026